FindTrial
Sign In

Diphenoxylate/Atropine

DRUG2 trials

Sponsors

University of California, San Francisco, National Cancer Institute (NCI)

Conditions

Breast AdenocarcinomaHER2-positive Breast CancerRecurrent Epithelial Cervical CarcinomaRecurrent Epithelial Endometrial CarcinomaRecurrent Platinum Resistant Epithelial Ovarian CarcinomaStage II Breast Cancer AJCC v6 and v7Stage IIA Breast Cancer AJCC v6 and v7Stage IIB Breast Cancer AJCC v6 and v7

Phase 2

Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib
CompletedNCT03094052
University of California, San FranciscoBreast Adenocarcinoma, HER2-positive Breast Cancer, Stage IIA Breast Cancer AJCC v6 and v7 +6
Start: 2018-10-09End: 2022-10-31Updated: 2025-06-26
Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas
TerminatedNCT06865677
National Cancer Institute (NCI)Recurrent Epithelial Cervical Carcinoma, Recurrent Epithelial Endometrial Carcinoma, Recurrent Platinum Resistant Epithelial Ovarian Carcinoma
Start: 2025-06-09End: 2025-07-01Updated: 2026-01-21